Slideshow
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
This slideshow reviews drug information for JEVTANA (cabazitaxel), indicated for metastatic prostate cancer.
Table of Contents
Slide 3: Indication, Dosage, and AdministrationSlide 7: Use in Specific PopulationsSlide 9: Clinical PharmacologySlide 13: Warnings and PrecautionsSlide 17: Clinical Safety and EfficacySlide 23: Drug Storage and SupplySlide 25: References